Harm Reduction Journal

Article	Citations
Decentralized HIV testing: comparing peer and mail-based distribution strategies to improve the reach of HIV self-testing among people who use drugs in Florida	124
Expanding single-venue services to better engage young people who inject drugs: insights from India	107
Egocentric network characteristics of people who inject drugs in the Chicago metro area and associations with hepatitis C virus and injection risk behavior	68
Contamination of a drug consumption room with drugs and potential risks for social health care workers	63
Welfare first: transforming harm reduction at UK festivals	55
The impact of institutionalization on the effectiveness of harm reduction: a qualitative study using drug users’ representations	52
Moving from ‘stigma reduction’ to ‘inclusion’: development of the inclusion collaborative at Nepean Blue Mountains Local Health District, New South Wales	52
Nasal administration of diacetylmorphine improved the adherence in a patient receiving heroin-assisted treatment	50
Assessment of two brands of fentanyl test strips with 251 synthetic opioids reveals “blind spots” in detection capabilities	48
Decolonizing drug policy	47
“The people who depended on us became expendable”: Experiences of frontline workers with lived and living expertise of drug use during the COVID-19 pandemic	46
A mixed-methods analysis of risk-reduction strategies adopted by syringe services program participants and non-syringe services program participants in New York City	45
The acceptability of overdose alert and response technologies: introducing the TPOM-ODART framework	44
HIV risk and prevention among clients of a delivery-based harm reduction service during an HIV outbreak among people who use drugs in northern rural Minnesota, USA	42
Associations with experience of non-fatal opioid overdose in British Columbia, Canada: a repeated cross sectional survey study	41
Fentanyl harm reduction strategies among Latinx communities in the United States: a scoping review	40
Managed alcohol: one community’s innovative response to risk management during COVID-19	39
Experiences of harm and mental ill-health among gay, bisexual and other men-who-have-sex-with-men who use methamphetamine or GHB/GBL in different combinations: findings from the COMeT study in Taiwan	39
Exploring perceived quality of life in long-term methadone-dependent patients: a qualitative study	38
Willingness to use and distribute HIV self-testing kits among people who inject drugs in the San Diego–Tijuana border region	38
Acceptability of supervised injection facilities among persons who inject drugs in upstate New York	32
Barriers to uptake of harm reduction techniques for GBMSM who use drugs in night-clubs and sex-on-premises venues in London and the Southeast: a mixed-methods, qualitative study	31
The implementation of safer drug consumption facilities in Scotland: a mixed methods needs assessment and feasibility study for the city of Edinburgh	30
Facilitators of and obstacles to practitioners’ adoption of harm reduction in cannabis use: a scoping review	30
First results of the French OCTOPUS survey among festival attendees: a latent class analysis	29

Vaping among Norwegians who smoke or formerly smoked: reasons, patterns of use, and smoking cessation activity	29
Improving access to HIV care among people who inject drugs through tele-harm reduction: a qualitative analysis of perceived discrimination and stigma	28
Harm reduction in substance use: perspectives and experiences of community volunteers and student interns in Durban, South Africa	28
Strategies used to reduce harms associated with fentanyl exposure among rural people who use drugs: multi-site qualitative findings from the rural opioid initiative	28
Online interventions and virtual day centres for young people who use drugs: potential for harm reduction?	27
“Naloxone? Not for me!” First cross-assessment by patients and healthcare professionals of the risk of opioid overdose	27
Will the Russian war in Ukraine unleash larger epidemics of HIV, TB and associated conditions and diseases in Ukraine?	27
Is fentanyl in everything? Examining the unexpected occurrence of illicit opioids in British Columbia’s drug supply	25
“Expected to happen”: perspectives on post-release overdose from recently incarcerated people with opioid use disorder	25
“To not feel fake, it can’t be fake”: co-creation of a harm reduction, peer-delivered, health-system intervention for people who use drugs	25
Integration of a community-based harm reduction program into a safety net hospital: a qualitative study	24
The war on drugs is a war on us: young people who use drugs and the fight for harm reduction in the Global South	24
Assessing the feasibility, acceptability and accessibility of a peer-delivered intervention to reduce harm and improve the well-being of people who experience homelessness with problem substance use:	24
Channelling and taxation in European online gambling markets: evolution and policy implications	24
Safety and feasibility of intranasal heroin-assisted treatment: 4-week preliminary findings from a Swiss multicentre observational study	24
Feeling safer: effectiveness, feasibility, and acceptability of continuous pulse oximetry for people who smoke opioids at overdose prevention services in British Columbia, Canada	23
Correction: Non-injection drug use among incarcerated people in Iran: Findings from three consecutive national bio-behavioral surveys	23
Identifying barriers and facilitators to COVID-19 vaccination uptake among People Who Use Drugs in Canada: a National Qualitative Study	23
Houselessness and syringe service program utilization among people who inject drugs in eight rural areas across the USA: a cross-sectional analysis	23
Harm reduction behaviours and harm experiences of people who use 3,4-methylenedioxymethamphetamine (MDMA) in Aotearoa New Zealand	22
Puff, Puff, Don’t Pass: harm reduction for cannabis use during a viral respiratory pandemic	22
Patient perspectives on naloxone receipt in the emergency department: a qualitative exploration	22
Challenges for drug checking services in Scotland: a qualitative exploration of police perceptions	22
Service utilization patterns and characteristics among clients of integrated supervised consumption sites in Toronto, Canada	22
Change in substance use among patients in opioid maintenance treatment: baseline to 1-year follow-up	22
Factors associated with gaps in naloxone knowledge: evidence from a 2022 great plains survey	21
A systematic review of interventions that impact alcohol and other drug-related harms in licensed entertainment settings and outdoor music festivals	21
Use and perceptions of Cannabidiol among individuals in treatment for opioid use disorder	21
Assessing healthcare cost changes associated with transitioning away from cigarette smoking using healthcare claims data: an exploratory study among adult male patients with COPD	20
Is use of opioid agonist treatment associated with broader primary healthcare use among men with recent injecting drug use histories following release from prison? A prospective cohort study	20
Analysis of different populations accessing online overdose response training and harm reduction supplies (ADORES)	20
One-month alcohol abstinence national campaigns: a scoping review of the harm reduction benefits	20
BeHERE’s effective virtual training to build capacity to support people who use drugs in non-substance use disorder settings	19
Reducing medical cannabis use risk among Veterans: A descriptive study	19
Total systems failure: police officers’ perspectives on the impacts of the justice, health, and social service systems on people who use drugs	18
“They make it too hard and too many hoops to jump”: system and organizational barriers to drug treatment during epidemic rates of opioid overdose	18
Prevalence of HIV and Hepatitis C and access to opioid substitution treatment among people who inject drugs in three cities in Croatia: findings from the second wave of respondent-driven sampling surv	18
An evaluation of first responders’ intention to refer to post-overdose services following SHIELD training	18
Not all screens are created equal: examination of surface features and other physical properties of commonly used screen materials for smoking drugs	18
Feasibility of paying people who use drugs cash to distribute naloxone within their networks	18
Best practices for community-based overdose education and naloxone distribution programs: results from using the Delphi approach	18
Anabolic-androgenic steroid testing as a tool for consumer engagement and harm reduction: a sequential explanatory mixed-method study	18
Structural stigma within inpatient care for people who inject drugs: implications for harm reduction	17
Evaluation of a novel therapeutic education programme for people with alcohol use disorder in France: a mixed-methods intervention study protocol (ETHER)	17
International harm reduction indicators are still not reached: results from a repeated cross-sectional study on drug paraphernalia distribution in Germany, 2021	17
Challenges in legitimizing further measures against smoking in jurisdictions with robust infrastructure for tobacco control: how far can the authorities allow themselves to go?	17
The joy and pain of being a harm reduction worker: a qualitative study of the meanings about harm reduction in Brazil	17
Involuntary discharge from drug or alcohol treatment programs in Vancouver, Canada	17
Correction: The managers’ perspectives on service providing in women’s harm reduction centers during the COVID-19 pandemic: mixed method study	17
The impact of supported accommodation on health and criminal justice outcomes of people released from prison: a systematic literature review	17

Law enforcement and syringe services program implementation in rural counties in Kentucky: a qualitative exploration	16
Switching behavior and changes in smoking behavior by menthol cigarette preference and menthol heated tobacco product use among adults in the United States who smoke cigarettes: an actual use study	16
Managing high-risk behaviours and challenges to prevent housing loss in permanent supportive housing: a rapid review	16
Creating safe, inclusive spaces for hospital-based health care staff and people who use drugs: an exploratory qualitative study in Vancouver, Canada	16
Quantifying the size and characteristics of a population of people who use drugs on the reservation lands of a tribal nation in the southern plains (USA)	16
Effects of a social network intervention on HIV seroconversion among people who inject drugs in Ukraine: moderation by network gender composition	16
Supervised consumption site enables cost savings by avoiding emergency services: a cost analysis study	15
The associations between social determinants of health, mental health, substance-use and recidivism: a ten-year retrospective cohort analysis of women who completed the connections programme in Austra	15
Feasibility, acceptability, and perceived usefulness of a community-evidence-based harm reduction intervention for sexualized stimulant use among Mexican gay, bisexual, and other men who have sex with	15
Injecting drugs alone during an overdose crisis in Vancouver, Canada	15
Development, acceptability and feasibility of a personalised, behavioural intervention to prevent bacterial skin and soft tissue infections among people who inject drugs: a mixed-methods Person-Based	15
“I feel like marijuana is the only drug that wouldn’t kill me”: perceptions of cannabis use in previously incarcerated Black men who have sex with other men	15
Setting foot in private spaces: extending the hepatitis C cascade of care to automatic needle/syringe dispensing machines, a mixed methods study	15
Prevalence and predictors of condom use among people who inject drugs in Georgia	15
A scoping review on barriers and facilitators to harm reduction care among youth in British Columbia, Canada	14
'It’s not going to be a one size fits all': a qualitative exploration of the potential utility of three drug checking service models in Scotland	14
Preloading with drugs before entry to the nighttime entertainment district: presentation, intoxication rates, and effects of police presence during assessment	14
Withdrawal during outpatient low dose buprenorphine initiation in people who use fentanyl: a retrospective cohort study	14
Gambling treatment service providers’ views about contingency management: a thematic analysis	14
Correction: A reduced exposure heated tobacco product was introduced then abruptly taken off United States shelves: results from a tobacco harm reduction natural experiment	14
The “goldfish bowl”: a qualitative study of the effects of heightened surveillance on people who use drugs in a rural and coastal Canadian setting	14
Predictors of concurrent heroin use among patients on opioid maintenance treatment in France: a multilevel study over 11 years	14
Differentiating the role of alcohol in young men’s use of substances with sex: A qualitative study	14
Are you tripping comfortably? Investigating the relationship between harm reduction and the psychedelic experience	14
Heroin pipe distribution to reduce high-risk drug consumption behaviors among people who use heroin: a pilot quasi-experimental study	14
Food access among people who inject drugs in West Virginia	14
50 years of harm reduction in Europe: high time for transformation	13
How an emergency department is organized to provide opioid-specific harm reduction and facilitators and barriers to harm reduction implementation: a systems perspective	13
Uptake of COVID-19 vaccination among people who inject drugs	13
Public health impact and harm reduction implications of xylazine-involved overdoses: a narrative review	13
Perspectives of U.S. harm reduction advocates on persuasive message strategies	13
Oral health risks in adults who use electronic nicotine delivery systems and oral nicotine pouches: a critical review of the literature and qualitative synthesis of the available evidence	13
Correction: Economic evaluation of the effect of needle and syringe programs on skin, soft tissue, and vascular infections in people who inject drugs: a microsimulation modelling approach	13
“I don’t let anybody die on my watch”: perspectives on the intersection of community overdose response and emergency medical services among people who use drugs in Seattle, WA	13
Xylazine co-occurrence with illicit fentanyl is a growing threat in the Deep South: a retrospective study of decedent data	13
The impact of COVID-19 on people who inject drugs in New York City: increased risk and decreased access to services	13
Scaling up low barrier wound care for people who use drugs: a mixed methods study	13
Ultrasound-guided phlebotomy in primary care for people who inject drugs	13
Patterns of use and adverse events reported among persons who regularly inject buprenorphine: a systematic review	13
Come back when you’re infected: pharmacy access to sterile syringes in an Arizona Secret Shopper Study, 2023	13
A Case report of a continuous ambulatory drug delivery (CADD) pump to deliver opioid agonist treatment in an acute care setting	13
‘We don’t live in a harm reduction world, we live in a prohibition world’: tensions arising in the design of drug alerts	12
The challenges, opportunities and strategies of engaging young people who use drugs in harm reduction: insights from young people with lived and living experience	12
Informed implementation practice – formative research of a mobile drug consumption room in Brno, Czech Republic	12
NPAideS: a drug-checking study among 3-methylmethcathinone (3-MMC) users	12
Challenges for the implementation of injectable opioid agonist treatment: a scoping review	12
HIV prevalence and continuum of care among incarcerated people in Iran from 2010 to 2017	12
The motives and methods of methamphetamine and ‘heroin’ co-use in West Virginia	12
Diverse psychotropic substances detected in drug and drug administration equipment samples submitted to drug checking services in Toronto, Ontario, Canada, October 2019–April 2020	12
Relational anonymity in reducing the harms of illicit drug use: accounts of users of dark web- and street-based services in Finland	12
Exploring substance use disorder discussions in Native American communities: a retrospective Twitter infodemiology study	12
The impact of JUUL market entry on cigarette sales: evidence from a major chain retailer in Canada	12
The impact of an integrated safer use space and safer supply program on non-fatal overdose among emergency shelter residents during a COVID-19 outbreak: a case study	12
High prevalence of hepatitis B virus susceptibility among persons undergoing community-based hepatitis C virus treatment	12
The hazardous (mis)perception of Self-estimated Alcohol intoxication and Fitness to drivE—an avoidable health risk: the SAFE randomised trial	12
Correction: Health workers’ perspectives of hepatitis B-related stigma among Aboriginal and Torres Strait Islander people in New South Wales, Australia	12
The quality of health information provided on web sites selling cannabis to consumers in Canada is poor	12
“We were building the plane as we were flying it, and we somehow made it to the other end”: syringe service program staff experiences and well-being during the COVID-19 pandemic	11
A simplified point-of-service model for hepatitis C in people who inject drugs in South Africa	11
The potential of new nicotine and tobacco products as tools for people who smoke to quit combustible cigarettes – a systematic review of common practices and guidance towards a robust study protocol t	11
Posttraumatic stress disorder in people who use drugs: syringe services program utilization, treatment need, and preferences for onsite mental health care	11
Progress and challenges in the elimination of hepatitis C among people who inject drugs in Germany: results of a pilot study for a national monitoring system, 10 years after the first data collection	11
Exploring the perception of key stakeholders toward khat policy approaches in Ethiopia: a qualitative study	11
Understanding Vietnam’s drug policy for amphetamine-type stimulants misuse	11
Challenges of the COVID-19 pandemic on women’s HIV harm reduction centers: a mixed-methods study	11
SARS-CoV-2 antibody prevalence, correlates, and access to harm reduction services among people who inject drugs living with and without HIV and their partners in Kenya	11
Selling sex in the context of substance use: social and structural drivers of transactional sex among men who use opioids in Maryland	11
The high frequency of alcohol advertising during televised English Premier League football games shown in Ethiopia	11
“We want everything in a one-stop shop”: acceptability and feasibility of PrEP and buprenorphine implementation with mobile syringe services for Black people who inject drugs	11
“I don’t want to die”: a qualitative study of coping strategies to prevent fentanyl-related overdose deaths among people who inject drugs and its implications for harm reduction policies	11
Differences by race and ethnicity in drug use patterns, harm reduction practices and barriers to treatment among people who use drugs in Rhode Island	11
Opioid overdose prevention education in Texas during the COVID-19 pandemic	11
Supporting syringe services programs in the initiation and scale-up of vaccine administration: findings from in-depth interviews	11
Mandatory verses voluntary self-tests for new online casino customers: effect on engagement, quality, gambling behavior and use of responsible gambling measures	10
Women, gender and drugs: between research and action	10
Patient perceptions of and experiences with stigma using telehealth for opioid use disorder treatment: a qualitative analysis	10
The relationship between police contacts for drug use-related crime and future arrests, incarceration, and overdoses: a retrospective observational study highlighting the need to break the vicious cyc	10
Non-disclosure of drug injection practices as a barrier to HCV testing: results from the PrebupIV community-based research study	10
Impact of Spanish gambling regulations on online gambling behavior and marketing strategies	10
Cohort profile: the Kyrgyzstan InterSectional Stigma (KISS) injection drug use cohort study	10

Nurse prescribing practices across the globe for medication-assisted treatment of the opioid use disorder (MOUD): a scoping review	10
Managing risks and harms associated with the use of anabolic steroids: a qualitative study	10
Vancouver’s Alcohol Knowledge Exchange: lessons learned from creating a peer-involved alcohol harm reduction strategy in Vancouver’s Downtown Eastside	10
Harm reduction must be recognised an essential public health intervention during crises	10
Prevalence and correlates of non-fatal overdose among people who use drugs: findings from rapid assessments in Massachusetts, 2017–2019	10
Correction: Reducing the harms of xylazine: clinical approaches, research deficits, and public health context	10
The impact of psychostimulant use on office based buprenorphine treatment retention	10
Point-of-care community drug checking technologies: an insider look at the scientific principles and practical considerations	10
Exploring the impact of the COVID-19 pandemic on healthcare and substance use service access among women who inject drugs: a qualitative study	10
Legal sourcing of ten cannabis products in the Canadian cannabis market, 2019–2021: a repeat cross-sectional study	10
Signals of increasing co-use of stimulants and opioids from online drug forum data	10
A scoping review of implementation considerations for harm reduction vending machines	9
Supervised on-site dosing in injectable opioid agonist treatment-considering the patient perspective. Findings from a cross-sectional interview study in two German cities	9
A cultural and political difference: comparing the racial and social framing of population crack cocaine use between the United States and France	9
Medical cannabis use in Australia seven years after legalisation: findings from the online Cannabis as Medicine Survey 2022–2023 (CAMS-22)	9
COVID-19 vaccination intention among people who use drugs in France in 2021: results from the international community-based research program EPIC	9
Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities	9
Philanthropic donor perspectives about providing harm reduction services for people living with HIV/AIDS in a hospital setting	9
Suicidal thoughts and behaviors among untreated illicit substance users: a population-based study	9
Participant perceptions on the acceptability and feasibility of a telemedicine-based HIV PrEP and buprenorphine/naloxone program embedded within syringe services programs: a qualitative descriptive ev	9
A longitudinal study of naloxone opioid overdose awareness and reversal training for first-year medical students: specific elements require reinforcement	9
Implementing Canada’s first national virtual phone based overdose prevention service: lessons learned from creating the National Overdose Response Service (NORS)	9
Community pharmacists’ attitudes toward and practice of pharmacy-based harm reduction services in Pittsburgh, PA: a descriptive survey	9
“No-one just does drugs during business hours!”: evaluation of a 24/7 primary needle and syringe program in St Kilda, Australia	9
An exploration of desired abstinent and non-abstinent recovery outcomes among people who use methamphetamine	9
Reducing the harms of cannabis use in youth post-legalization: insights from Ontario youth, parents, and service providers	9
Comprehensive drug policies increase trust in local government: an analysis of authorities’ and residents’ perspectives in rural US Appalachian and Midwestern counties	9
Dealing with low access to harm reduction: a qualitative study of the strategies and risk environments of people who use drugs in a small Swedish city	9
“As safe as possible”: a qualitative study of opioid withdrawal and risk behavior among people who use illegal opioids	9
A confirmed case of xylazine-induced skin ulcers in a person who injects drugs in Miami, Florida, USA	9
Ups and downs of addiction harm reduction in Iran: key insights and implications for harm reduction policy and policing	9
CENTER-ing Black voices: incorporating lived experience across the research process to advance equity in drug treatment and outcomes	9
‘Why would we not want to keep everybody safe?’ The views of family members of people who use drugs on the implementation of drug consumption rooms in Scotland	9
Patterns of care contacts in the final year of life among opioid overdose fatalities in southern Sweden: a latent class analysis	9
Overdose responses among rural people who use drugs: A multi-regional qualitative study	9
Muslims perceptions of safe alcohol use: a qualitative study in the Gulf Council Cooperation countries	9
Balancing public health and privacy rights: a mixed-methods study on disclosure obligations of people living with HIV to their partners in China	8
The changing landscape of pharmaceutical alternatives to the unregulated drug supply during COVID-19	8
Fanning the flame: analysing the emergence, implications, and challenges of Australia’s de facto war on Nicotine	8
Repeated point-prevalence of switching away from smoking after electronic nicotine delivery systems (ENDS) purchase	8
Rural community-based participatory research with families of people who use drugs: key considerations from a multi-provincial research partnership	8
Low-dose overlap initiation with split tablets of buprenorphine in intubated intensive care unit patients with opioid use disorder	8
Long-acting injectable depot buprenorphine from a harm reduction perspective in patients with ongoing substance use and multiple psychiatric comorbidities: a qualitative interview study	8
Interaction and conflict between outreach workers and research officers in implementing collaborative action research in the field of harm reduction: a qualitative study	8
Estimating lung cancer risk from e-cigarettes and heated tobacco products: applications of a tool based on biomarkers of exposure and of potential harm	8
Assessment of harm reduction receipt and infectious diseases outcomes in United States Veterans with opioid use disorder and history of injection drug use	8
Perceived harms and protective behavioural strategies among khat chewers: a qualitative study in Jimma, Ethiopia	8
Association between socioeconomic and motherhood characteristics with receiving community-based treatment services among justice-involved young female drug users: a retrospective cohort study in Taiwa	8
An individual-based dynamic model to assess interventions to mitigate opioid overdose risk	8
Opioid consumption frequency and its associations with potential life problems during opioid agonist treatment in individuals with prescription-type opioid use disorder: exploratory results from the O	8
Substance use, injection risk behaviors, and fentanyl-related overdose risk among a sample of PWID post-Hurricane Maria	8
Community-based drug checking at syringe service programs in New York City observe an increasing prevalence of xylazine from 2021 through 2024	8
The impact of Taiwan’s implementation of a nationwide harm reduction program in 2006 on the use of various illicit drugs: trend analysis of first-time offenders from 2001 to 2017	8
Naloxone prescriptions among patients with a substance use disorder and a positive fentanyl urine drug screen presenting to the emergency department	8
Intention to get naloxone among patients prescribed opioids for chronic pain	7
Correction: Assessing feasibility of a modified same-day test-and-treat model for hepatitis C among rural people who inject drugs	7
Pre-exposure prophylaxis (PrEP) for HIV prevention among people who inject drugs: a global mapping of service delivery	7
Correction: Increasing access to screening for blood-borne viruses and sexually transmissible infections for Aboriginal and Torres Strait Islander Australians: evaluation of the Deadly Liver Mob progr	7
A qualitative investigation of the feasibility and acceptability of lower risk gambling guidelines	7
How do contextual factors influence naloxone distribution from syringe service programs in the USA: a cross-sectional study	7
A qualitative study of benzodiazepine/z-drug and opioid co-use patterns and overdose risk	7
“I don’t go to funerals anymore”: how people who use opioids grieve drug-related death in the US overdose epidemic	7
Self-exclusion and breaching of self-exclusion from gambling: a repeated survey study on the development of a nationwide self-exclusion service	7
A randomised, crossover, clinical study to assess nicotine pharmacokinetics and subjective effects of the BIDI® stick ENDS compared with combustible cigarettes and a comparator ENDS in adult smokers	7
Drug preparation, injection-related infections, and harm reduction practices among a national sample of individuals entering treatment for opioid use disorder	7
Peer-facilitated treatment access for hepatitis C: the Live Hep C Free project	7
People who inject oral morphine favor experimentation with injectable opioid substitution	7
Exploration of novel harm reduction approaches to increase client engagement (ENHANCE): protocol for a prospective cohort study	7
Acute pain and self-directed discharge among hospitalized patients with opioid-related diagnoses: a cohort study	7
Exploring the impact of the COVID-19 pandemic on syringe services programs in rural Kentucky	7
Economic evaluation of the effect of needle and syringe programs on skin, soft tissue, and vascular infections in people who inject drugs: a microsimulation modelling approach	7
The theory of preloading: A cognitive-behavioural motivational model	7
Measuring sustainability of opioid agonist therapy programs in the context of transition from Global Fund support	7
Correlates of fentanyl preference among people who use drugs in Rhode Island	7
An approach designed to fail deaf children and their parents and how to change it	7
Unpacking the Effects of Decriminalization: Understanding Drug Use Experiences and Risks among Individuals Who Use Drugs in British Columbia	7
Harm reduction in the Heartland: public knowledge and beliefs about naloxone in Nebraska, USA	7
Difficulty accessing supervised consumption services during the COVID-19 pandemic among people who use drugs in Vancouver, Canada	7
Correction to: An exploratory non-randomized study of a 3-month electronic nicotine delivery system (ENDS) intervention with people accessing a homeless supported temporary accommodation service (STA)	6
The Bronze Age of drug checking: barriers and facilitators to implementing advanced drug checking amidst police violence and COVID-19	6
Xylazine awareness and attitudes among people who use drugs in Ohio, 2023–2024	6
A step change model analysis of the establishment of pill testing in one Australian jurisdiction	6
Opioid-related harms and experiences of care among people in justice settings in New South Wales, Australia: evidence from the National Ambulance Surveillance System	6
Identifying the facilitators of Iran’s alcoholic beverage black market and presenting solutions for harm reduction: a qualitative document analysis	6
Harm reduction in photovoice knowledge mobilization with 2S/LGBTQ+ youth who use(d) drugs: A community showcase	6
Accessing needle exchange services in disasters for remote areas of Aotearoa New Zealand	6
The utility of a new point-of-care test for synthetic cannabinoids: a mixed-methods study in people who use synthetic cannabinoids and stakeholders	6
How a sample of English stop smoking services and vape shops adapted during the early COVID-19 pandemic: a mixed-methods cross-sectional survey	6
The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in a rural American state	6
Study assessing the effectiveness of overdose prevention centers through evaluation research (SAFER): an overview of the study protocol	6
Prevalence and correlates of using opioids alone among individuals in a residential treatment program in Michigan: implications for overdose mortality prevention	6
Opioid-specific harm reduction in the emergency department: how staff provide harm reduction and contextual factors that impact their capacity to engage in harm reduction practice	6
Mind the G(ap): bridging prevention needs and approaches for GHB/GBL users and their social environment	6
Reported adverse events related to use of hepatitis C virus direct-acting antivirals with opioids: 2017–2021	6
Community-based respondent-driven sampling as a strategy for drug use surveillance in a large French urban area	6